Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China. (Q47940789)

6 February 2018

title

Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China. (English)

1 reference

6 February 2018

main subject

cardiovascular disease

1 reference

1 reference

Chun Li

1

1 reference

6 February 2018

X R Wang

2

1 reference

6 February 2018

H J Ji

3

1 reference

6 February 2018

X Y Zhang

4

1 reference

6 February 2018

X F Li

5

1 reference

6 February 2018

L Z Wang

6

1 reference

6 February 2018

C H Wang

7

1 reference

6 February 2018

Y F Wang

8

1 reference

6 February 2018

Rong Yang

9

1 reference

6 February 2018

G C Wang

10

1 reference

6 February 2018

Xin Lu

11

1 reference

6 February 2018

Ping Zhu

12

1 reference

6 February 2018

L N Chen

13

1 reference

6 February 2018

H T Jin

14

1 reference

6 February 2018

J T Liu

15

1 reference

6 February 2018

X Y Liu

16

1 reference

6 February 2018

Lin Sun

17

1 reference

6 February 2018

H Y Chen

18

1 reference

6 February 2018

Ping Wei

19

1 reference

6 February 2018

J X Wang

20

1 reference

6 February 2018

L F Cui

21

1 reference

6 February 2018

Rong Shu

22

1 reference

6 February 2018

B L Liu

23

1 reference

6 February 2018

Z L Zhang

24

1 reference

6 February 2018

G T Li

25

1 reference

6 February 2018

Z B Li

26

1 reference

6 February 2018

Jing Yang

27

1 reference

6 February 2018

J F Li

28

1 reference

6 February 2018

Bin Jia

29

1 reference

6 February 2018

F X Zhang

30

1 reference

6 February 2018

J M Tao

31

1 reference

6 February 2018

S L Han

32

1 reference

6 February 2018

J Y Lin

33

1 reference

6 February 2018

M Q Wei

34

1 reference

6 February 2018

X M Liu

35

1 reference

6 February 2018

Dan Ke

36

1 reference

6 February 2018

S X Hu

37

1 reference

6 February 2018

Cong Ye

38

1 reference

6 February 2018

X Y Yang

39

1 reference

6 February 2018

Hao Li

40

1 reference

6 February 2018

C B Huang

41

1 reference

6 February 2018

Ming Gao

42

1 reference

6 February 2018

Bei Lai

43

1 reference

6 February 2018

X F Li

44

1 reference

6 February 2018

L J Song

45

1 reference

6 February 2018

Yi Wang

46

1 reference

6 February 2018

X Y Wang

47

1 reference

6 February 2018

Y D Tang

48

1 reference

6 February 2018

Yin Su

49

1 reference

6 February 2018

Rong Mu

50

1 reference

6 February 2018

Z G Li

51

1 reference

6 February 2018

publication date

24 March 2017

1 reference

6 February 2018

published in

Clinical Rheumatology

1 reference

6 February 2018

volume

36

1 reference

6 February 2018

page(s)

1023-1029

1 reference

6 February 2018

issue

5

1 reference

6 February 2018

Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10067-017-3596-7

Cardiovascular risk and rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-017-3596-7

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-017-3596-7

Towards improving cardiovascular risk management in patients with rheumatoid arthritis: the need for accurate risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-017-3596-7

Could cardiovascular disease risk stratification and management in rheumatoid arthritis be enhanced?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-017-3596-7

Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-017-3596-7

Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-017-3596-7

Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-017-3596-7

Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-017-3596-7

Risk assessment for coronary heart disease in rheumatoid arthritis and osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-017-3596-7

Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-017-3596-7

Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-017-3596-7

Classical cardiovascular disease risk factors associate with vascular function and morphology in rheumatoid arthritis: a six-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-017-3596-7

Progression of coronary artery atherosclerosis in rheumatoid arthritis: comparison with participants from the Multi-Ethnic Study of Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-017-3596-7

Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-017-3596-7

Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-017-3596-7

Chloroquine reduces blood pressure and forearm vascular resistance and increases forearm blood flow in healthy young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-017-3596-7

Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-017-3596-7

Insulin resistance and impaired beta cell function in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-017-3596-7

Hydroxychloroquine in decompensated, treatment-refractory noninsulin-dependent diabetes mellitus. A new job for an old drug?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-017-3596-7

Biochemical characterization of ADP-ribose polymer metabolism in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-017-3596-7

Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-017-3596-7

The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-017-3596-7

Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-017-3596-7

An evaluation of risk factors for major adverse cardiovascular events during tocilizumab therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-017-3596-7

Abatacept improves whole-body insulin sensitivity in rheumatoid arthritis: an observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-017-3596-7

Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-017-3596-7

TNFA −308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-017-3596-7

Clinical and laboratory factors associated with interstitial lung disease in rheumatoid arthritis

21 January 2018

1 reference

12 December 2020

Rheumatoid factor, smoking, and disease severity: associations with mortality in rheumatoid arthritis

1 reference

12 December 2020

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

1 reference

12 December 2020

Cardiovascular risk in rheumatoid arthritis: comparing TNF-α blockade with nonbiologic DMARDs

1 reference

12 December 2020

Tumor necrosis factor α inhibitor use and decreased risk for incident coronary events in rheumatoid arthritis

1 reference

12 December 2020

No significant change in arterial stiffness in RA after 6 months and 1 year of rituximab treatment

1 reference

12 December 2020

Short-term improvement of endothelial function in rituximab-treated rheumatoid arthritis patients refractory to tumor necrosis factor alpha blocker therapy

1 reference

12 December 2020

Atherosclerosis--an inflammatory disease

1 reference

12 December 2020

What can we learn from treatment-induced changes in rheumatoid factor and anti-citrullinated Peptide antibodies?

1 reference

12 December 2020

Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study

1 reference

12 December 2020

Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years

1 reference

12 December 2020

Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis.

1 reference

12 December 2020

Mortality in rheumatoid arthritis: 2008 update.

1 reference

12 December 2020

10.1007/S10067-017-3596-7

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

28342151

1 reference

6 February 2018